Ciencia Básica y Patogénesis

Área de la Ciencia:

• Neuroscience; Vascular Biology; Diabetology

Sus antecedentes:

• Vascular Contributions to Cognitive Impairment and Dementia (VCID) is a major cause of Alzheimer's disease and related dementias (ADRD), affecting millions.; Type 2 Diabetes (T2D) significantly increases the risk (2-4x) of cognitive impairment, a critical factor in ADRD.; Existing preclinical models often neglect vascular mechanisms, focusing instead on hypoperfusion-induced neuroinflammation.

Objetivo del estudio:

• To develop and validate a novel multi-etiology vascular model for VCID/ADRD in both control and diabetic rats.; To investigate the combined impact of microemboli and carotid artery occlusion on brain pathology and cognitive function in the context of diabetes.

Principales métodos:

• A novel multi-etiology model involving microemboli (ME) injection followed by unilateral common carotid artery occlusion (UCCAO) was applied to control and diabetic Wistar rats.; Behavioral tests (Novel Object Recognition, open-field), histological staining (H&E, LFB), immunoblotting (senescence, hypoxia markers), and plasma biomarker analysis were employed.; A novel z-scoring holistic behavior analysis method was utilized for comprehensive behavioral assessment.

Principales resultados:

• Significant increases in striatal tissue damage (p=0.0012) and reduced corpus callosum myelination were observed in diabetic rats subjected to the VCID model.; Diabetic rats exhibited anxiety-like behaviors and impaired cognitive function, indicated by a significantly lower z-score (-1.15) compared to controls.; Increased hypoxia (HIF1α) and senescence (p21) markers were found in the cortex, and diabetic rats showed a blunted plasma biomarker response (GFAP, Neurofilament L) post-injury, suggesting impaired repair.

Conclusiones:

• The developed multi-etiology model effectively replicates key aspects of VCID/ADRD in a diabetic context.; This model highlights the detrimental role of diabetes in exacerbating brain injury and impairing recovery mechanisms following vascular insults.; Further research using this clinically relevant model may uncover novel therapeutic targets for VCID/ADRD, particularly in diabetic populations.